BioSpace News Archive

Policy

North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray

North Carolina sued Insys on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid epidemic.

December 22, 2017

·

1 min read

Sotera Employees Misappropriated Masimo Trade Secr

Policy

United Therapeutics to Pay $210M to Resolve U.S. Kickback Probe

United Therapeutics Corporation will pay $210M to resolve U.S. claims that the drugmaker used a charity as a conduit to illegally cover Medicare patients’ out-of-pocket drug costs in order to eliminate price sensitivity and to boost sales.

December 22, 2017

·

1 min read

Biotech Bay

3 Hot Cancer Immunotherapies Waiting To Blast Off in 2018

Immuno-oncology therapeutics have revolutionized certain types of cancer treatments, and they are, in many ways, as close to miracle cures as we’ve seen in decades.

December 22, 2017

·

2 min read

·

Mark Terry

Gemini Therapeutics Banks $42.5M to Bring Precisio

Biotech Bay

3 Marijuana Biotech Stock Winners for 2018

Next year should be enormously important for Canadian marijuana stocks, as the country moves forward with legalization of recreational marijuana.

December 22, 2017

·

1 min read

Pharm Country

9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To

Pfizer may be the surprise strong-growth stock for next year.

December 22, 2017

·

2 min read

·

Mark Terry

BioMidwest

Here Is The Future of Medtech in 2018

“2018 will prove to be a landmark year for wearable technology as it continues to carve out its space within mainstream healthcare...”

December 22, 2017

·

1 min read

Policy

Teva Sees Approval at Finish Line for Anti-CGRP Migraine Treatment

With a priority review voucher in hand, Teva is expecting the FDA to rule on its new migraine treatment fremanezumab by June.

December 22, 2017

·

4 min read

·

Alex Keown

Amneal and Impax to Marry, Creating the 5th Larges

Policy

Medical Device Tax Comes Back January 1

For the first time in years, the medical device tax will take effect Jan. 1, after Congress left town without delivering on a long-promised delay or repeal.

December 22, 2017

·

1 min read

Policy

FDA Proposes Easing of Medical Device Malfunctioning Reporting

The U.S. Food and Drug Administration on Friday said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis to cut down on repeated reviews of common problems.

December 22, 2017

·

1 min read

JHL Biotech Proposes Voluntary Delisting from Taiwan Exchange

The biosimilar company, which has a $419M market capitalization, operates in Taiwan and Wuhan, China.

December 22, 2017

·

1 min read